Odyssey Health (ODYY) Net Cash Flow (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Odyssey Health | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 8,985.53% |
| Oct 31, 2025 | -59.10% |
| Jul 31, 2025 | 497.35% |
| Apr 30, 2025 | 91.43% |
| Jan 31, 2025 | -190.66% |
| Oct 31, 2024 | 180.91% |
| Jul 31, 2024 | 36.45% |
| Apr 30, 2024 | -215.44% |
| Jan 31, 2024 | -119.71% |
| Oct 31, 2023 | 351.90% |
| Jul 31, 2023 | 203.10% |
| Apr 30, 2023 | -134.98% |
| Jan 31, 2023 | 33.26% |
| Oct 31, 2022 | -110.04% |
| Jul 31, 2022 | 62.60% |
| Apr 30, 2022 | 139.72% |
| Jan 31, 2022 | -297.69% |
| Oct 31, 2021 | 95.13% |
| Jul 31, 2021 | -233.38% |
| Apr 30, 2021 | 672.59% |
| Jan 31, 2021 | -199.95% |
| Oct 31, 2020 | 532.89% |
| Jul 31, 2020 | 52.03% |
| Apr 30, 2020 | 123.99% |
| Jan 31, 2020 | -53.70% |
| Oct 31, 2019 | -138.84% |
| Jul 31, 2019 | 55,504.32% |
| Apr 30, 2019 | 19.95% |
| Jan 31, 2019 | -161.14% |
| Oct 31, 2018 | 110.69% |
| Jul 31, 2018 | -200.24% |
| Apr 30, 2018 | 151.58% |
| Jan 31, 2018 | -486.45% |
| Oct 31, 2017 | -117.22% |
| Jul 31, 2017 | 295.56% |
| Apr 30, 2017 | -175.78% |
| Jan 31, 2017 | 573.14% |
| Oct 31, 2016 | 87.68% |
| Jul 31, 2016 | -120.12% |
| Apr 30, 2016 | 1,595.09% |
| Jan 31, 2016 | -1,056.88% |
| Oct 31, 2015 | 147.89% |
| Jul 31, 2015 | 96.87% |
| Apr 30, 2015 | -193.60% |
| Jan 31, 2015 | -20,050.00% |